Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 1 hour 1 min ago
Top 5 Companies Hiring in the Boston Area
Top 5 Companies Hiring in the Boston Area 5/9/2024
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data 4/9/2024
Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs
Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs 4/9/2024
FDA Backs BrainStorm’s Design for Phase IIIb Trial in Early-Stage ALS
FDA Backs BrainStorm’s Design for Phase IIIb Trial in Early-Stage ALS 4/9/2024
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk 4/9/2024
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report 4/9/2024
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids
Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids 5/8/2024
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More
ASGCT2024: FDA’s Marks on Accelerated Approval, Gene Therapy Costs and More 5/8/2024
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy 5/8/2024
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters
AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters 5/8/2024
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient
Pfizer Halts Dosing in Late-Stage DMD Study Following Death of Young Patient 5/8/2024
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm
Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcomm 5/8/2024
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird 5/8/2024
Generative AI Finds Its Footing in Drug Development
Generative AI Finds Its Footing in Drug Development 5/8/2024
BMS, J&J Losses Not the End of IRA Legal Battle
BMS, J&J Losses Not the End of IRA Legal Battle 5/8/2024
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs 4/8/2024
BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win
BMS Sees Early ROI for $14B Karuna Buy with Phase III Schizophrenia Win 4/8/2024
ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint
ACC24 Roundup: Novo, Ionis Tout Cardio Victories and Boehringer, Lilly Disappoint 4/8/2024
5 Successful Phase III Oncology Trials in Q1
5 Successful Phase III Oncology Trials in Q1 4/8/2024
The Next Wave of ADCs Could Treat Evasive Solid Tumors
The Next Wave of ADCs Could Treat Evasive Solid Tumors 4/8/2024
World Pharma News
- Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance
- Herpes cure with gene editing makes progress in laboratory studies
- Scientists pinpoint new vaccine "booster" that promotes potent anti-tumour immunity
- New treatment could reverse hair loss caused by an autoimmune skin disease
- AI predicts tumor-killing cells with high accuracy